Clarithromed may be available in the countries listed below.
Ingredient matches for Clarithromed
Clarithromycin is reported as an ingredient of Clarithromed in the following countries:
- Belgium
International Drug Name Search
Clarithromed may be available in the countries listed below.
Clarithromycin is reported as an ingredient of Clarithromed in the following countries:
International Drug Name Search
Generic Name: nalidixic acid (Oral route)
nal-i-DIX-ik AS-id
Commonly used brand name(s):
In the U.S.
Available Dosage Forms:
Therapeutic Class: Antibiotic
Chemical Class: Non-Fluorinated Quinolone
Nalidixic acid is used to treat infections of the urinary tract. This medicine belongs to the group of medicines known as quinolone antibiotics. It works by killing the bacteria and preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.
This medicine is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of nalidixic acid in infants younger than 3 months of age. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of nalidixic acid in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require an adjustment in the dose for patients receiving nalidixic acid.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
Take this medicine only as directed by your doctor. Do not take more of it, do not take it more often, and do not take it for a longer time than your doctor ordered.
This medicine may be taken with or without food. Drink plenty of fluids every day while you are using nalidixic acid.
If you or your child are taking aluminum, calcium, or magnesium-containing antacids, didanosine oral liquid (e.g., Videx®), iron supplements, multivitamins, zinc, or sucralfate (e.g., Carafate®), do not take them at the same time that you take this medicine. It is best to take these medicines at least 2 hours before or 2 hours after the nalidixic acid.
To help clear up your infection completely, keep taking this medicine for the full time of treatment, even if you or your child begin to feel better after a few days. Do not miss any doses.
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
If you will be taking this medicine for more than 2 weeks, it is very important that your doctor check you or your child's progress at regular visits. Blood tests may be needed to check for unwanted effects.
If your or your child's symptoms do not improve within 2 days, or if they become worse, check with your doctor.
Do not breastfeed while you are using this medicine.
Do not use melphalan (e.g., Alkeran®) or other similar cancer medicines while you are taking this medicine. Using these medicines together may increase your risk for more serious side effects.
This medicine may cause serious allergic reactions, including anaphylaxis, which can be life-threatening and require immediate medical attention. Call your doctor right away if you or your child have a rash; itching; hives; hoarseness; shortness of breath; trouble with breathing; trouble with swallowing; or any swelling of your hands, face, or mouth after you take this medicine.
Nalidixic acid may cause diarrhea, and in some cases it can be severe. Do not take any medicine to treat diarrhea without first checking with your doctor. Diarrhea medicines may make the diarrhea worse or make it last longer. If you have any questions about this or if mild diarrhea continues or gets worse, check with your doctor.
Tell your doctor right away if you or your child start having numbness, tingling, or burning pain in your hands, arms, legs, or feet. These may be symptoms of a condition called peripheral neuropathy.
This medicine may rarely cause inflammation or tearing of a tendon (the cord that attaches muscles to bones). The risk of having tendon problems may be increased if you are over 60 years of age or if you are also using steroid medicines (e.g., dexamethasone, prednisolone, prednisone, Medrol®). If you or your child get sudden pain in a tendon after exercise (e.g., in the ankle, back of the knee or leg, shoulder, elbow, or wrist), stop taking nalidixic acid and check with your doctor right away. Rest and do not exercise until the doctor has made sure that you have not injured or torn the tendon.
This medicine may cause blurred vision or other vision problems. It may also cause some people to become dizzy, drowsy, or less alert than they are normally. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert or able to see well. If these reactions are especially bothersome, check with your doctor.
This medicine may increase the central nervous system (CNS) stimulant effects of caffeine-containing foods or beverages, such as chocolate, cocoa, tea, coffee, and cola drinks. Avoid eating or drinking large amounts of these foods or beverages while using this medicine. If you have questions about this, check with your doctor.
Nalidixic acid may cause your skin to be more sensitive to sunlight than it is normally. Exposure to sunlight, even for brief periods of time, may cause a skin rash, itching, redness or other discoloration of the skin, or a severe sunburn. When you begin using this medicine:
If you or your child have a severe reaction from the sun, stop using this medicine and check with your doctor right away.
This medicine may cause false test results with some urine glucose (sugar) tests. If you or your child are diabetic, check with your doctor before changing your diet or the dose of your diabetes medicine while you are using nalidixic acid.
Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Get emergency help immediately if any of the following symptoms of overdose occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Neggram side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Frusehexal may be available in the countries listed below.
Furosemide is reported as an ingredient of Frusehexal in the following countries:
International Drug Name Search
Farmaciclin may be available in the countries listed below.
Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Farmaciclin in the following countries:
International Drug Name Search
Generic Name: guaifenesin (Oral route)
gwye-FEN-e-sin
In the U.S.
In Canada
Available Dosage Forms:
Therapeutic Class: Expectorant
Guaifenesin is used to help clear mucus or phlegm (pronounced flem) from the chest when you have congestion from a cold or flu. It works by thinning the mucus or phlegm in the lungs.
This medicine is available both over-the-counter (OTC) and with your doctor's prescription.
Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Although there is no specific information comparing use of guaifenesin in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults. However, check with your doctor before using this medicine in children who have a chronic cough, such as occurs with asthma, or who have an unusually large amount of mucus or phlegm with the cough. Children with these conditions may need a different kind of medicine. Also, guaifenesin should not be given to children and infants younger than 2 years of age unless you are directed to do so by your doctor.
Do not give any over-the-counter (OTC) cough and cold medicine to a baby or child under 4 years of age. Using these medicines in very young children might cause serious or possibly life-threatening side effects .
Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults. Although there is no specific information comparing use of guaifenesin in the elderly with use in other age groups, this medicine is not expected to cause different side effects or problems in older people than it does in younger adults.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
This section provides information on the proper use of a number of products that contain guaifenesin. It may not be specific to Bidex 400. Please read with care.
Drinking plenty of water while taking guaifenesin may help loosen mucus or phlegm in the lungs.
For patients taking the extended-release capsule form of this medicine:
For patients taking the extended-release tablet form of this medicine:
The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
If your cough has not improved after 7 days or if you have a fever, skin rash, continuing headache, or sore throat with the cough, check with your doctor. These signs may mean that you have other medical problems.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: Bidex 400 side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Treating HIV infection in combination with other medicines.
Nelfinavir Powder is an HIV protease inhibitor. It works by blocking a substance that is needed for the HIV virus to multiply.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Nelfinavir Powder. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Nelfinavir Powder. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Nelfinavir Powder may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Nelfinavir Powder as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Nelfinavir Powder.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; gas; loss of appetite; nausea; stomach pain.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever, chills, or sore throat; mental or mood changes; suicidal thoughts or actions; symptoms of high blood sugar (eg, confusion; flushed face; fruit-like breath odor; increased thirst, hunger, or urination; unusual drowsiness); unusual bleeding or bruising.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Nelfinavir side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.
Store Nelfinavir Powder at room temperature, between 59 and 86 degrees F (15 and 30 degrees C), in its original container. Store away from heat, light, and moisture. Do not store in the bathroom. Keep Nelfinavir Powder out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Nelfinavir Powder. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Ergokod may be available in the countries listed below.
Dihydroergotoxine is reported as an ingredient of Ergokod in the following countries:
International Drug Name Search
Generic Name: naphazoline ophthalmic (na FAZ oh leen)
Brand Names: AK-Con, Albalon, Allerest Eye Drops, Clear Eyes, Degest 2, Estivin II, Nafazair, Naphcon, Naphcon Forte, VasoClear, Vasocon
Naphazoline ophthalmic causes constriction of blood vessels in the eyes. It also decreases itching and irritation of the eyes.
Naphazoline ophthalmic may also be used for purposes other than those listed in this medication guide.
If you wear contact lenses, remove them before applying naphazoline ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication. Naphazoline ophthalmic may contain a preservative (benzalkonium chloride), which may cause discoloration of contact lenses.
Before using this medication, tell your doctor if you
have any type of heart condition, including high blood pressure;
take any medicines to treat a heart condition;
have asthma;
have diabetes; or
have thyroid problems.
You may not be able to use naphazoline ophthalmic, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
If you wear contact lenses, remove them before applying naphazoline ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication. Naphazoline ophthalmic may contain a preservative (benzalkonium chloride), which may cause discoloration of contact lenses.
Use naphazoline eye drops exactly as directed by your doctor, or follow the directions that accompany the package. If you do not understand these instructions, ask your doctor, pharmacist, or nurse to explain them to you.
Wash your hands before and after using the eye drops.
To apply the eye drops:
If you wear contact lenses, remove them before applying naphazoline ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication. Naphazoline ophthalmic may contain a preservative (benzalkonium chloride), which may cause discoloration of contact lenses.
Tilt the head back slightly and pull down on the lower eyelid. Position the dropper above the eye. Look up and away from the dropper. Squeeze out a drop and close the eye. Apply gentle pressure to the inside corner of the eye (near the nose) for about 1 minute to prevent the liquid from draining down your tear duct. Repeat the process in the other eye if needed..
Apply the missed dose as soon as you remember. However, if it is almost time for the next regularly scheduled dose, skip the missed dose and apply the next one as directed. Do not use a double dose of this medication.
An overdose of this medication is unlikely to be harmful. If you do suspect an overdose, or if the drops have been ingested (taken by mouth), contact an emergency room or poison control center for advice.
If you wear contact lenses, remove them before applying naphazoline ophthalmic. Ask your doctor if contact lenses can be reinserted after application of the medication. Naphazoline ophthalmic may contain a preservative (benzalkonium chloride), which may cause discoloration of contact lenses.
If you experience any of the following serious side effects, stop using naphazoline ophthalmic and seek emergency medical attention or contact your doctor immediately:
an allergic reaction (difficulty breathing; closing of the throat; swelling of the lips, face, or tongue; or hives);
an irregular or fast heart rate; or
high blood pressure (severe headache, blurred vision, or flushed skin).
Other, less serious side effects may be more likely to occur. Continue to use naphazoline ophthalmic and talk to your doctor if you experience
burning, stinging, pain, or increased redness of the eye;
tearing or blurred vision;
headache;
tremor;
nausea;
sweating;
nervousness;
dizziness; or
drowsiness.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome. You may report side effects to FDA at 1-800-FDA-1088.
Do not use other eye medications during treatment with naphazoline ophthalmic except under the direction of your doctor.
Although drug interactions between naphazoline ophthalmic and drugs taken by mouth are not expected, they can occur. Before using this medication, tell your doctor if you are taking any of the following medicines:
a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), tranylcypromine (Parnate), or phenelzine (Nardil); or
a beta-blocker such as propranolol (Inderal), metoprolol (Lopressor, Toprol XL), or labetalol (Normodyne, Trandate).
You may not be able to use naphazoline ophthalmic, or you may require a dosage adjustment or special monitoring during treatment if you are taking any of the medicines listed above.
Drugs other than those listed here may also interact with naphazoline ophthalmic. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines, including vitamins, minerals, and herbal products.
See also: Naphcon Forte side effects (in more detail)
Generic Name: fluticasone topical (floo TIK a sone TOP i kal)
Brand Names: Cutivate
Fluticasone is a steroid. It reduces the actions of chemicals in the body that cause inflammation, redness, and swelling.
Fluticasone topical (for the skin) is used to treat the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis.
Fluticasone topical may also be used for purposes not listed in this medication guide.
Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body. Do not use fluticasone topical in larger amounts, or for longer than recommended by your doctor. Do not apply to your face, underarms, or groin area unless your doctor tells you to.
To make sure you can safely use fluticasone topical, tell your doctor if you have any type of skin infection.
Also tell your doctor if you have diabetes. Steroid medicines may increase the glucose (sugar) levels in your blood or urine. You may also need to adjust the dose of your diabetes medications.
Use exactly as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label. Topical steroid medicine can be absorbed through the skin, which may cause steroid side effects throughout the body.
Apply a small amount to the affected area and rub it gently into the skin. Do not apply the medication over a large area of skin, or use it long-term on the face. Do not use fluticasone topical on broken or infected skin. Also avoid using this medication in open wounds.
If you are treating your scalp, part the hair and apply the medicine directly to the scalp, rubbing in gently. Avoid washing or rubbing the treated scalp area right away. Wait until the medicine has dried thoroughly.
If you use this medication long-term, your blood may need to be tested. Visit your doctor regularly.
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.
An overdose of fluticasone topical is not expected to produce life threatening symptoms. However, long term use of high steroid doses can lead to symptoms such as thinning skin, easy bruising, changes in the shape or location of body fat (especially in your face, neck, back, and waist), increased acne or facial hair, menstrual problems, impotence, or loss of interest in sex.
Do not use this medication to treat skin conditions around your mouth, rectum, or genital areas. Do not apply to your face, underarms, or groin area unless your doctor tells you to.
Avoid using other steroid medications on the areas you treat with fluticasone topical unless you doctor tells you to.
Although the risk of serious side effects is low when fluticasone topical is applied to the skin, side effects can occur if the medication is absorbed into your bloodstream.
blurred vision, or seeing halos around lights;
headache, back ache, weakness, confusion, mood changes;
sleep problems (insomnia);
weight gain, puffiness in your face;
muscle weakness, feeling tired; or
high blood sugar (increased thirst, increased urination, hunger, dry mouth, fruity breath odor, drowsiness, dry skin, blurred vision, weight loss).
Less serious side effects may include:
mild skin itching, burning, peeling, or dryness;
changes in color of treated skin;
thinning or softening of your skin;
skin rash or irritation around your mouth;
redness or crusting around your hair follicles;
blisters, pimples, or crusting of treated skin; or
stretch marks.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Dermatologic Lesion:
Cream: Apply a thin film to affected area twice daily.
Ointment: Apply sparingly in a thin film twice daily.
Usual Adult Dose for Atopic Dermatitis:
Cream: Apply a thin film to affected area once or twice daily.
Ointment: Apply sparingly in a thin film twice daily.
Lotion: Apply sparingly in a thin film to affected area once daily.
Usual Pediatric Dose for Dermatologic Lesion:
3 months to 12 years:
Cream: Apply a thin film to affected area twice daily. Safety and efficacy of use > 4 weeks has not been established.
13 years or older:
Ointment: Apply sparingly in a thin film to affected area twice daily
Usual Pediatric Dose for Atopic Dermatitis:
3 months to 11 months:
Cream: Apply a thin film to affected area twice daily. Safety and efficacy of use more than 4 weeks has not been established.
1 year to 11 years:
Lotion: Apply sparingly in a thin film to affected area once daily.
13 years or older:
Ointment: Apply sparingly in a thin film to affected area twice daily
It is not likely that other drugs you take orally or inject will have an effect on topically applied fluticasone topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Generic Name: roflumilast (roe FLOO mi last)
Brand Names: Daliresp
Roflumilast reduces inflammation in the lungs that leads to COPD (chronic obstructive pulmonary disease).
Roflumilast is used to prevent worsening of chronic obstructive pulmonary disease (COPD) in people with severe COPD and chronic bronchitis.
Roflumilast may also be used for purposes not listed in this medication guide.
There are many other drugs that can make roflumilast less effective and should not be used at the same time. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Before you take roflumilast, tell your doctor if you have liver disease or a history of depression, mental illness, or suicidal thoughts or actions.
You may have unusual thoughts or behavior, or thoughts about suicide, while taking this medicine. Tell your doctor if you have new or worsening depression, or suicidal thoughts. Your family or other caregivers should also be alert to changes in your mood or symptoms.
There are many other drugs that can make roflumilast less effective and should not be used at the same time. This includes:
bosentan (Tracleer);
dexamethasone (Cortastat, Dexasone, Solurex, DexPak);
St. John's wort;
rifabutin (Mycobutin), rifampin (Rifadin, Rifater, Rifamate), or rifapentine (Priftin);
a barbiturate such as butabarbital (Butisol), secobarbital (Seconal), pentobarbital (Nembutal), or phenobarbital (Solfoton);
HIV medication such as efavirenz (Sustiva, Atripla), etravirine (Intelence), nevirapine (Viramune), or ritonavir (Norvir, Kaletra);
medicines to treat narcolepsy, such as armodafanil (Nuvigil) or modafanil (Progivil); or
seizure medication such as carbamazepine (Carbatrol, Equetro, Tegretol), felbamate (Felbatol), oxcarbazepine (Trileptal), phenytoin (Dilantin), or primidone (Mysoline).
To make sure you can safely take roflumilast, tell your doctor if you have any of these other conditions:
liver disease;
a history of depression, mental illness, or suicidal thoughts or actions.
You may have unusual thoughts or behavior, or thoughts about suicide, while taking this medicine. Tell your doctor if you have new or worsening depression, or suicidal thoughts. Your family or other caregivers should also be alert to changes in your mood or symptoms.
Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.
Roflumilast is usually taken once per day, with or without food. Follow your doctor's instructions.
See also: Roflumilast dosage (in more detail)
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
Overdose symptoms may include fast or pounding heartbeats, cold or clammy skin, or feeling like you might pass out.
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
You may have unusual thoughts or behavior, or thoughts about suicide, while taking this medicine. Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, depression, trouble sleeping, or if you feel impulsive, or you have thoughts about suicide or hurting yourself.
rapid and unintended weight loss;
tremors;
pain or burning when you urinate;
Less serious side effects may include:
nausea, diarrhea, stomach pain;
loss of appetite, minor weight loss;
dizziness;
runny or stuffy nose;
back pain; or
flu symptoms.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:
To reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations:
500 mcg orally once a day, with or without food.
Tell your doctor about all other medicines you use, especially:
birth control pills;
cimetidine (Tagamet);
conivaptan (Vaprisol);
imatinib (Gleevec);
isoniazid (for treating tuberculosis);
lidocaine (Xylocaine);
methoxsalen (Oxsoralen, Uvadex, 8-Mop);
primaquine (anti-malaria medication);
an antidepressant such as fluvoxamine (Luvox) or nefazodone;
an antibiotic such as ciprofloxacin (Cipro), clarithromycin (Biaxin), erythromycin (E.E.S., EryPed, Ery-Tab, Erythrocin, Pediazole), norfloxacin (Noroxin), ofloxacin (Floxin), or telithromycin (Ketex);
antifungal medication such as itraconazole (Sporanox), ketoconazole (Nizoral), miconazole (Oravig), o thiabendazole (Mintezol);
heart or blood pressure medication such as amiodarone (Cordarone, Pacerone), mexiletine (Mexitil), nicardipine (Cardene) or quinidine (Quin-G);
HIV/AIDS medicine such as atazanavir (Reyataz), delavirdine (Rescriptor), indinavir (Crixivan), nelfinavir (Viracept), saquinavir (Invirase), or ritonavir (Norvir, Kaletra);
This list is not complete and other drugs may interact with roflumilast. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
See also: roflumilast side effects (in more detail)
Oxytetracyclin-Prednisolon-Augensalbe Jenapharm may be available in the countries listed below.
Oxytetracycline hydrochloride (a derivative of Oxytetracycline) is reported as an ingredient of Oxytetracyclin-Prednisolon-Augensalbe Jenapharm in the following countries:
Prednisolone is reported as an ingredient of Oxytetracyclin-Prednisolon-Augensalbe Jenapharm in the following countries:
International Drug Name Search
Opticlox may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Cloxacillin benzathine (a derivative of Cloxacillin) is reported as an ingredient of Opticlox in the following countries:
International Drug Name Search
Epaxal
Hepatitis A Vaccine
inactivated, virosome
The full name of the vaccine is Epaxal, emulsion for injection in pre-filled syringe, Hepatitis A vaccine (inactivated, virosome)
Epaxal is provided as a clear, colourless liquid in a pre-filled syringe that contains a single 0.5 ml dose. The vaccine is available in packs of one or 10 pre-filled syringes.
Epaxal is a vaccine which contains killed hepatitis A virus. It works by causing your body to produce antibodies (your body’s natural defence system) against the hepatitis A virus. These antibodies will protect you against hepatitis A infection from about 2 to 4 weeks after the injection. Epaxal can be used in children from 1 year of age and adults.
Some general information about hepatitis A is given at the end of this leaflet.
Epaxal will only protect you against hepatitis A and not against any other type of hepatitis virus or any other illness that can cause hepatitis (inflammation of the liver).
You should not have Epaxal if the answer to any of the following questions is “YES”. If you are unsure of anything or have questions, please talk to your doctor, nurse or pharmacist before the vaccine is given.
Also, vaccination may have to be delayed if the answer to the following question is “YES”:
If the answer to the following question is “YES”, please tell your doctor, nurse or pharmacist before the vaccine is administered.
Also, please note the following:
Please take note that if you normally have a flu vaccine, you will still need to have it. Although there are small amounts of influenza virus protein in Epaxal, the vaccine will not protect you against catching flu.
Epaxal should only be given to pregnant women if it is clearly necessary. If you are or think that you might be pregnant, discuss this with your doctor or nurse before having Epaxal.
It is not known if the vaccine passes into the breast milk. Talk to your doctor or nurse if you are breast-feeding.
Having this vaccine occasionally gives people dizziness or headaches that might affect your ability to drive or use machines.
Please inform your doctor or nurse if you are taking or have recently taken any other medicines, even those not prescribed.
You can take tablets for the prevention of malaria on the same days as having doses of Epaxal. There is no need to stop the medicine.
Epaxal can be given at the same time as vaccines against yellow fever, typhoid fever, poliomyelitis, diphtheria, tetanus, meningococci A + C and influenza.
Vaccines given at the same time as Epaxal will be given using a separate syringe and at different injection sites.
You can also receive a dose of human gamma globulin (antibody) if it is necessary to protect you immediately against hepataitis A infection. The gammaglobulin should be given at a different injection site.
Your doctor or nurse will inject the vaccine into the muscle, usually in your upper arm. In people who have conditions that make them bleed easily or whose blood does not clot normally, Epaxal can be given just below the skin.
The dose for all ages from one year upwards is 0.5 ml.
Protection against hepatitis A following the first vaccine dose should last for at least one year. To make sure that protection against hepatitis A is continued, a second dose of 0.5 ml should be given. It is best if this is given between 6 and 12 months after the first dose but it is known that a very good immune response to the booster occurs when the second dose is given up to 4 years later. Even if more than 4 years have gone by, you can still have a second dose of Epaxal
to boost your immunity.
People who have poor immunity to infections for any reason, should have a second dose earlier than other people, usually between 1 and 6 months after the first dose.
If you received your first vaccine dose with another hepatitis A vaccine, you can still be given Epaxal for the booster vaccination. Also, people who received Epaxal for the first dose can be boosted with another hepatitis A vaccine if necessary.
Like all medicines, Epaxal can have side effects.
Serious allergic reactions are always a possibility after receiving a vaccine.
These reactions (reported by less than 1 in 10,000 people) may include difficulty in breathing, blue discolouration of the tongue or lips, low blood pressure (causing dizziness) and collapse. When these signs or symptoms occur they usually
develop very quickly after the injection is given and while the person affected is still in the clinic or doctor’s surgery. If any of these symptoms occur after leaving the place where your injection was given, you must consult a doctor immediately.
Very common side effects (reported by more than 1 in 10 people) are pain at the injection site, tiredness and headaches.
Common side effects (reported by less than 1 in 10 but more than 1 in a 100 people) are:
Uncommon side effects (reported by less than 1 in a 100 but more than 1 in a 1000 people) are:
Very rarely there may be reactions involving the nerves. You should tell your doctor immediately if you notice any of the following: pins and needles, loss of feeling or numbness and problems moving your arms or legs. Also, blood tests that measure how the liver is working sometimes show some slight changes for a brief period after vaccination.
If you notice any other effects after the vaccination that are not mentioned here, tell your doctor, nurse or pharmacist.
Epaxal should be stored at 2–8 °C (in a refrigerator) and protected from light. It must not be frozen. The vaccine must not be used after the expiry date.
Keep Epaxal out of the reach and sight of children.
This leaflet was last revised in March 2006
Hepatitis A is a liver disease caused by the hepatitis A virus. You can catch the virus by eating or drinking contaminated food or water. The virus is present in the stools of infected people, even if they show no signs of the disease. You can catch hepatitis A infection in any country but the risk is highest in countries where sanitation and food and water hygiene are poor.
After catching the virus, it can be up to six weeks before signs of illness are seen. Some people have the virus and never get ill but they can still infect other people during this time.
The main signs of the illness include a headache, fever, sickness and jaundice (yellowing of the skin and eyes). These signs are all due to an inflammation of the liver while it is infected with the virus. Most patients get better usually after a couple of months, but a few people may take up to a year to make a full recovery. Whilst recovering, people affected with hepatitis A may be unable to work, they may not be able to drink alcohol and may need to avoid certain foods according
to their doctors’ advice. Severe complications are very rare but sometimes the liver stops working and very special hospital care is needed until the infection gets better. The severity of the disease increases with age, and adults above
the age of 40–50 years are at an increased risk to suffer from complications, which can sometimes be fatal.
There are many other types of virus that can cause hepatitis. The signs may be the same as in hepatitis A infection but the other viruses are not always caught through food and drink. Epaxal can help to protect you against infection with
the hepatitis A virus only.
900622gb1pr.004
Gabapentina Combix may be available in the countries listed below.
Gabapentin is reported as an ingredient of Gabapentina Combix in the following countries:
International Drug Name Search
FOR PUPPIES AND SMALL DOGS
Durvet Triple Wormer™ Flavored Chewables
Package contents: Blisters of 2 or 12 chewables
DRUG FACTS
Pyrantel Pamoate (30mg) and Praziquantel (30mg)
De-wormer for Small Dogs and Puppies Only (6.0 to 25 pounds)
For the treatment and control of
Keep this and all medication out of the reach of children. To obtain product information, including a Material Safety Data Sheet (MSDS), call 1-800-821-5570.
When Using This Product:
Vomiting, loose stools (with or without blood) and decreased activity following treatment. If you notice these signs, contact a veterinarian.
Each flavored chewable contains 30 mg of pyrantel pamoate and 30 mg of praziquantel. The dose for each drug is 2.27 mg per pound of body weight (5 mg/kg). Please refer to the following dosing table for help finding the right dose for your dog.
| Dog Weight | Number of Chewables |
|---|---|
| 6.0 to 12.0 pounds | 1 |
| 12.1 to 25 pounds | 2 |
| More than 25 pounds | Use the 114 mg size |
Consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. De-worming schedules may vary depending on the climate where you live and the activity of your dog.
Re-treatment of your dog may be necessary as determined by laboratory fecal examination and/or if your dog is living where re-infections are likely to occur. Consult your veterinarian for assistance in the diagnosis and prevention of re-infection. In case of re-infection with tapeworms (Dipylidium caninum), consult your veterinarian for advice on how to remove fleas from the dog and the environment.
Store at controlled room temperature of 59-86°F (15-30°C).
To report a suspected adverse reaction, call 1-800-821-5570
If you have questions or comments about this product, please write: Durvet, Inc., PO Box 279, Blue Springs, MO 64013
Manufactured for:
Durvet, Inc., 100 S.E. Magellan Drive, Blue Springs, MO 64014
MADE IN USA
NADA141-261, Approved by FDA ACAV P002632-1 06/07
NDC 30798-185-61
FOR PUPPIES AND SMALL DOGS
TripleWormer™
(pyrantel pamoate/praziquantel)
2
tablets
CHEWABLE FLAVORED DOG DE-WORMER TABLETS
Broad Spectrum
De-Wormer
For Puppies & Small Dogs
6 lbs. to 25 lbs.
For the treatment and control of:
roundworms (Toxocara canis, Toxascaris leonina);
hookworms (Ancylostoma caninum, Ancylostoma
braziliense, Uncinaria stenocephala);
tapeworms (Dipylidium caninum,Taenia
pisiformis) in dogs and puppies.
Active ingredient: Each flavored chewable contains
30 mg pyrantel pamoate and 30 mg praziquantel.
KEEP OUT OF REACH OF CHILDREN
FOR USE ONLY AS DIRECTED ON PACKAGE INSERT & BACK PANEL
NET CONTENTS: 2 FLAVORED TABLETS
NADA #141-261, APPROVED BY FDA
durvet
| Triple Wormer pyrantel pamoate and praziquantel tablet, chewable | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| NADA | NADA141261 | 03/06/2010 | |
| Labeler - Durvet, Inc. (056387798) |
| Registrant - Virbac AH, Inc. (131568396) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| Virbac Bridgeton | 808558100 | MANUFACTURE | |